ID1 promotes expansion and survival of primary erythroid cells and is a target of JAK2V617F-STAT5 signaling

The discovery of JAK2V617F as an acquired mutation in the majority of patients with myeloproliferative disorders (MPDs) and the key role of the JAK2-STAT5 signaling cascade in normal hematopoiesis has focused attention on the downstream transcriptional targets of STAT5. Despite evidence of its vital...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Wood, Andrew D., Chen, Edwin, Donaldson, Ian J., Hattangadi, Shilpa, Burke, Karly A., Dawson, Mark A., Miranda-Saavedra, Diego, Lodish, Harvey F., Green, Anthony R., Göttgens, Berthold
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2009
Aiheet:
Myeloid Neoplasia
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3942052/
https://ncbi.nlm.nih.gov/pubmed/19571317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-02-206573
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia